Approval from school administration was obtained, in addition to parental consent and verbal consent from each participant.
Written informed consent for sampling and questionnaire administration was obtained from representatives of the study households.
Prior approval of the hospital administration was obtained before beginning the survey.
The tumour to WB ratio for MIBI before DMBA (control) and after DMBA or asiaticoside administration was obtained.
Before the data was collected, official letter from Lund University administration was obtained to ask consent from AAU administration as well as from study participants.
Intravenous access for fluid and drug administration was obtained via cannulation of the tail vein with a sterile G24 catheter (BD, Sandy, UT, USA).
Informed consent for ketamine administration was obtained from parents, guardians, or patients (18-year-old or older) at the time of its administration as part of their clinical care.
Plasma TP300 concentration 1 h after administration was obtained only at the doses of 2, 8, 10 and 12 mg/m and the mean concentration was 3.48, 2.34, 7.37 and 18.4 ng/mL, respectively.
Brain concentrations at steady-state 5 times greater than those found after peripheral β1 administration were obtained.
The clinical efficacy parameters for SAXA administration were obtained from the literature; local standard costs were considered for drug acquisition, adverse events (AEs), and micro/macrovascular complications.
Determinations were done after 12 hours of fasting; to maintain both appropriate light-dark cycle and fasting, samples for glycogen synthesis after 12 hours of insulin administration were obtained at 6 00 PM and for glucose oxidation at 3 00 and 11 00 AM.
